Filing Details

Accession Number:
0001722024-19-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-30 18:12:17
Reporting Period:
2019-05-28
Accepted Time:
2019-05-30 18:12:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1676725 Ideaya Biosciences Inc. IDYA Pharmaceutical Preparations (2834) 474268251
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1722024 Alexandria Venture Investments, Llc 385 East Colorado Blvd., Suite 299
Pasadena CA 91101
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-28 382,384 $0.00 382,384 No 4 C Direct
Common Stock Acquisiton 2019-05-28 50,000 $10.00 432,384 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A preferred stock Disposition 2019-05-28 3,149,405 $0.00 307,066 $0.00
Common Stock Series B preferred stock Disposition 2019-05-28 772,499 $0.00 75,318 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 10.2564 shares of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on May 28, 2019, for no additional consideration. The shares had no expiration date.
  2. Not applicable.